Diazooxohexanoate-based prodrug of a GLS inhibitor for lymphoma

DISEASE CATEGORY: Cancer

INDICATION: Lymphoma

Cell culture studies identified a diazooxohexanoate-based prodrug of a GLS inhibitor that could help treat

Read the full 181 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE